Rob Tressler has authored over 30 peer-reviewed articles and publications and is an inventor on numerous patents. He has been vital in the success of Excellos since 2014 and is currently managing the process and analytical development teams to support our clients. Previously he was the CSO at the San Diego Blood Bank and has held executive scientific roles at Geron, Inc. and Cellerant Therapeutics. Rob’s scientific focus is stem cell and T cell biology, oncology, and anti-aging. He achieved his Ph.D. from the University of Texas in Cancer Biology and has a Master's Degree in Microbiology. He is also a member of the American Association of Blood Banks, The International Society of Cell Therapy, and the American Society of Hematology.